Bevacizumab is used to treat some types of cancer (e.g. colorectal cancer, breast cancer, brain cancer, endometrial cancer, lung cancer and ovarian cancer).
It is a monoclonal antibody which blocks VEGF (Vascular Endothelial Growth Factor), thus preventing the growth of blood vessels which supply oxygen and nutrients to the cancer cells.
Inform your healthcare professional if:
Early Side Effects (within days after receiving Bevacizumab)
Delayed Side Effects (within days to weeks after receiving Bevacizumab)
Disclaimers
If you take more than the recommended dose, please seek medical advice immediately. The information provided on this page does not replace information from your healthcare professional. Please consult your healthcare professional for more information.
This article is jointly developed by members of the National Medication Information workgroup. The workgroup consists of cluster partners (National Healthcare Group, National University Health System and SingHealth), community pharmacies (Guardian, Unity and Watsons) and Pharmaceutical Society of Singapore. The content does not reflect drug availability and supply information in pharmacies and healthcare institutions. You are advised to check with the respective institutions for such information.
Last updated on May 2022
Use Medicine Order Service on HealthBuddy.
Get reminders and chart progress on HealthBuddy.